Introduction: Pancreatic ductal adenocarcinoma (PDAC) develops through a series of precursor lesions, beginning with acinar-to-ductal metaplasia (ADM) and progressing to pancreatic intraepithelial neoplasia and invasive cancer. While genetic alterations such as KRAS mutations are established drivers of this process, the contribution of the neural microenvironment to early pancreatic carcinogenesis remains poorly understood.
Introduction:
Pancreatic ductal adenocarcinoma (PDAC) develops through a series of precursor lesions, beginning with acinar-to-ductal metaplasia (ADM) and progressing to pancreatic intraepithelial neoplasia and invasive cancer. While genetic alterations such as KRAS mutations are established drivers of this process, the contribution of the neural microenvironment to early pancreatic carcinogenesis remains poorly understood.
Problem Statement:
Neural remodeling is increasingly recognized as an important component of the pancreatic tumor microenvironment, yet the mechanisms linking nerve growth and epithelial transformation during the earliest stages of PDAC development are unclear. Understanding these interactions may reveal opportunities to intercept pancreatic cancer before invasive disease develops.
Summary:
This study identifies a previously unrecognized bidirectional communication network between pancreatic epithelial cells and neural elements that promotes pancreatic carcinogenesis. The investigators demonstrated that inflammation and oncogenic KRAS-driven ADM actively stimulate neurite outgrowth, while neural remodeling in turn facilitates metaplastic transformation and disease progression. Central to this interaction is ganglioside-mediated signaling, particularly involving the metabolite GM3, which serves as a key molecular mediator of neural-acinar crosstalk. Through comprehensive lipidomic, transcriptomic, and functional analyses, the authors identified β-1,4-galactosyltransferase 5 as a critical regulator of ganglioside biosynthesis that is progressively overexpressed across ADM, pancreatic intraepithelial neoplasia, and PDAC lesions in both murine and human tissues. Functional studies confirmed that this enzyme plays an essential role in initiating metaplastic changes and driving progression toward invasive pancreatic cancer. Importantly, pharmacologic inhibition of β-1,4-galactosyltransferase 5 suppressed neuronal growth, disrupted the neural-metaplastic niche, and attenuated ADM formation and progression. These findings establish neural remodeling as an active participant rather than a passive bystander in pancreatic carcinogenesis. The study provides compelling evidence that ganglioside-driven neural-epithelial interactions create a permissive microenvironment for tumor initiation and progression. By identifying glycosphingolipid metabolism and neuronal–ADM signaling as actionable targets, this work opens new avenues for early intervention strategies aimed at preventing the development of pancreatic cancer at its premalignant stages.
Introduction: Intrahepatic cholangiocarcinoma (ICC) is an aggressive primary liver cancer with poor prognosis and limited treatment options. While ICC has traditionally been considered a malignancy of biliary epithelial cells, increasing evidence suggests that hepatocytes can...
Introduction: Liver fibrosis is the key determinant of long-term outcomes in metabolic dysfunction-associated steatohepatitis (MASH). Activated hepatic stellate cells (HSCs) drive fibrogenesis, but effective antifibrotic therapies remain unavailable. This study investigated whether blocking the succinate–GPR91...
Introduction: The progression from metabolic dysfunction-associated fatty liver (MAFL) to metabolic dysfunction-associated steatohepatitis (MASH) is driven by complex interactions between hepatocytes and immune cells. This study identifies a novel spatial mechanism in the periportal (PP)...
Introduction: Cardiovascular–Kidney–Metabolic (CKM) syndrome recognizes the close interaction between obesity, type 2 diabetes, chronic kidney disease, and cardiovascular disease. This review highlights the emerging role of the gut microbiome, particularly butyrate-producing bacteria, as a central...
• Small intestinal adenocarcinoma (SIA) is a rare gastrointestinal cancer with limited disease-specific prognostic biomarkers and generally poor outcomes. • This nationwide Dutch population-based study evaluated whether three routinely available immunohistochemical markers—CK7, CK20, and CDX2—have...
Introduction: Metabolic dysfunction–associated steatotic liver disease (MASLD) is closely linked to insulin resistance and type 2 diabetes, with the liver traditionally viewed as a key regulator of blood glucose through hepatic glucose production. However, emerging...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.